LDH Assay: Protocol for Measuring Cytotoxicity and Cell Viability

The lactate dehydrogenase (LDH) assay is a colorimetric or fluorometric method that quantifies the release of the cytosolic enzyme LDH into the culture medium upon plasma membrane damage, providing a direct measure of cytotoxicity and an indirect measure of cell viability. This assay is particularly useful for evaluating the cytotoxic effects of chemical compounds, nanoparticles, drugs, or biological agents in adherent and suspension cell cultures, and is widely employed in toxicology, pharmacology, and biomedical research. The LDH assay offers a rapid, quantitative, and high-throughput-compatible alternative to viability assays that measure metabolic activity, such as MTT or Alamar Blue, because it directly assesses membrane integrity rather than cellular metabolism.

At a Glance

Scientific Principle

The LDH assay relies on the enzymatic activity of lactate dehydrogenase, a stable cytosolic enzyme present in virtually all mammalian cells. When the plasma membrane is compromised—either through necrosis, late-stage apoptosis, or mechanical damage—LDH is released into the surrounding culture medium. The amount of LDH in the supernatant correlates directly with the number of damaged or lysed cells.

The detection reaction involves two coupled enzymatic steps. First, LDH catalyzes the oxidation of lactate to pyruvate while reducing NAD+ to NADH. Second, in the presence of the catalyst diaphorase, NADH reduces a tetrazolium salt (typically INT, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride) to a colored formazan product. The formazan absorbs light at 490–500 nm, and the absorbance is proportional to LDH activity. In fluorometric versions, a resazurin-based substrate is used, producing fluorescent resorufin.

The key distinction from metabolic assays (e.g., MTT, MTS, Alamar Blue) is that LDH release measures membrane integrity rather than mitochondrial function. This is important because some treatments may impair metabolism without immediately compromising membrane integrity, or conversely, may cause membrane damage without affecting metabolic enzymes. Studies have demonstrated that LDH release and metabolic activity assays can yield complementary but not identical results. For example, in evaluating silica-based materials for ocular drug delivery, researchers found that Alamar Blue and LDH assays provided different perspectives on cell tolerability, with LDH release offering a more direct measure of membrane damage [5].

Materials and Instrumentation

Cell Culture Components

• Cell line of interest: Non-pathogenic, BSL-1 compatible cell lines (e.g., SH-SY5Y, HeLa, fibroblasts, epithelial cells) as described in the approved evidence [1][2][3][4][5]
• Complete culture medium: Appropriate for the specific cell line, typically containing 5–10% fetal bovine serum (FBS)
• Assay medium: Serum-free or low-serum medium (≤1% FBS) to reduce background LDH activity from serum
• Phosphate-buffered saline (PBS): For washing cells
• Cell culture plates: 96-well plates are standard for high-throughput LDH assays; 24-well or 6-well plates can be used with appropriate volume adjustments

LDH Assay Reagents

• LDH detection reagent: Commercial kits (e.g., CytoTox 96® Non-Radioactive Cytotoxicity Assay, LDH-Glo™ Cytotoxicity Assay) or laboratory-prepared reagent containing lactate, NAD+, INT, and diaphorase
• Lysis solution: 10X lysis buffer (typically 1% Triton X-100 in culture medium) for maximum LDH release control
• Stop solution: 1 M acetic acid or 1 M HCl (for colorimetric assays) to terminate the enzymatic reaction

Instrumentation

• Microplate reader: Capable of measuring absorbance at 490–500 nm (colorimetric) or fluorescence at excitation ~560 nm/emission ~590 nm (fluorometric)
• Multichannel pipette: For precise and consistent reagent addition across 96-well plates
• Centrifuge: For pelleting cells and debris from supernatant (optional but recommended)
• Incubator: Humidified, 37°C, 5% CO₂

Selection Considerations

The choice between colorimetric and fluorometric detection depends on sensitivity requirements and available instrumentation. Fluorometric assays typically offer 10–100 times greater sensitivity, making them suitable for low-cell-density experiments or when minimal LDH release is expected. Colorimetric assays are more economical and compatible with standard absorbance readers. Commercial kits provide optimized reagent concentrations and stability, while laboratory-prepared reagents require careful quality control but offer cost savings for high-volume laboratories.

Controls and Experimental Design

Proper controls are essential for accurate LDH assay interpretation. The assay requires three fundamental control conditions, each serving a distinct purpose.

Spontaneous LDH Release Control (Low Control)

This control measures the baseline LDH release from untreated, healthy cells. It accounts for the minimal LDH that leaks from viable cells during normal culture and handling. Prepare wells containing cells in assay medium without any test compound. The volume of assay medium should match the test wells exactly.

Maximum LDH Release Control (High Control)

This control defines the total LDH content of the cells, representing 100% lysis. Add lysis solution (typically 10X concentration to achieve 1X final) to wells containing cells in assay medium. Incubate for 45–60 minutes at 37°C to ensure complete lysis. The lysis time should be validated for each cell type, as some cells require longer incubation for complete release.

Background Control (Medium Only)

This control measures LDH activity present in the assay medium itself, primarily from serum components. Include wells containing assay medium without cells. This value is subtracted from all other measurements. If using serum-free medium, the background is typically very low but should still be measured.

Additional Controls

• Test compound control: Wells containing test compound in medium without cells to detect any direct interference with the LDH detection reaction
• Vehicle control: Wells containing cells treated with the solvent or vehicle used to dissolve test compounds (e.g., DMSO at the same final concentration)
• Positive cytotoxicity control: A known cytotoxic agent (e.g., 0.1% Triton X-100, 1 µM staurosporine) to validate assay performance

Experimental Design Considerations

• Replicates: Use at least triplicate wells for each condition
• Cell density: Optimize seeding density to ensure cells are in logarithmic growth phase at the time of treatment. Typical densities range from 5,000–20,000 cells per well for a 96-well plate, depending on cell size and growth rate
• Treatment duration: Standard treatment times range from 4–72 hours, depending on the experimental question. Shorter treatments (4–24 hours) are typical for acute cytotoxicity, while longer treatments (48–72 hours) assess chronic effects
• Plate layout: Distribute controls and treatments across the plate to minimize positional effects. Avoid edge wells if evaporation is a concern

Conceptual Workflow

Step 1: Cell Seeding and Treatment

Seed cells in a 96-well plate at the optimized density in complete culture medium. Allow cells to attach and recover for 24 hours (or until reaching 70–80% confluence for adherent cells). Remove the medium and wash cells gently with PBS to remove any LDH released during handling. Add assay medium (serum-free or low-serum) containing test compounds at appropriate concentrations. Include all control wells as described above. Incubate for the desired treatment period.

Step 2: Supernatant Collection

At the end of the treatment period, carefully transfer the supernatant from each well to a fresh 96-well plate or microcentrifuge tubes. Avoid disturbing the cell monolayer. If necessary, centrifuge the supernatant at 250–300 × g for 5 minutes to remove any detached cells or debris. This step is critical because intact cells contain LDH that would artificially increase the signal.

Step 3: LDH Detection Reaction

Add an equal volume of LDH detection reagent to each supernatant sample. For commercial kits, follow the manufacturer's recommended ratio (typically 50 µL reagent to 50 µL supernatant). Incubate the reaction at room temperature in the dark for 20–30 minutes. Protect from light because the tetrazolium salt is photosensitive.

Step 4: Stop Reaction and Measure Absorbance

Add stop solution (if using a colorimetric assay) to terminate the enzymatic reaction. Measure absorbance at 490–500 nm using a microplate reader within 1 hour of stopping the reaction. For fluorometric assays, measure fluorescence directly without stopping.

Step 5: Data Calculation

Calculate percent cytotoxicity using the following formula:

% Cytotoxicity = [(Experimental Absorbance – Spontaneous Release Absorbance) / (Maximum Release Absorbance – Spontaneous Release Absorbance)] × 100

All absorbance values should first have the background control (medium only) subtracted. The spontaneous release control represents the baseline LDH release from healthy cells, while the maximum release control represents total cellular LDH content.

Quality Checks and Validation

Assay Validation Criteria

• Spontaneous release: Should be less than 10–15% of maximum release. Higher values indicate excessive cell stress or handling damage
• Maximum release: Should show consistent absorbance values across replicate wells (coefficient of variation <10%)
• Background signal: Should be minimal (typically <0.1 absorbance units for colorimetric assays)
• Linearity: The assay should demonstrate linearity with cell number. Prepare a standard curve using serial dilutions of lysed cells to verify that absorbance is proportional to cell number

Interference Checks

Test compounds can interfere with the LDH detection reaction through several mechanisms:

• Direct enzyme inhibition: Some compounds inhibit LDH or diaphorase activity
• Color interference: Colored compounds may absorb at the detection wavelength
• Quenching: Fluorescent compounds may quench the fluorometric signal

To assess interference, prepare a control containing the test compound at the highest concentration used in the experiment, added to a known amount of LDH (e.g., from lysed cells). Compare the measured signal to the expected signal. If interference is detected, consider using a different detection method or performing a compound removal step (e.g., dialysis or size-exclusion filtration).

Positive Control Performance

Include a known cytotoxic agent (e.g., 0.1% Triton X-100) in each experiment. The positive control should consistently yield >90% cytotoxicity. If the positive control fails, the assay reagents or procedure may be compromised.

Result Interpretation

Percent Cytotoxicity Values

• 0–10%: Generally considered non-cytotoxic (within normal spontaneous release range)
• 10–30%: Mild cytotoxicity; may be biologically relevant depending on the experimental context
• 30–60%: Moderate cytotoxicity
• 60–100%: Severe cytotoxicity

These thresholds are guidelines and should be interpreted in the context of the specific cell type, treatment duration, and experimental objectives. Some cell types have higher baseline LDH release, and some treatments may cause partial membrane damage without complete lysis.

Comparison with Other Viability Assays

LDH assay results should be interpreted alongside complementary assays. For example, in studies evaluating silver nanoparticle cytotoxicity, LDH release may correlate with metabolic activity assays but can reveal differences in the mechanism of cell death [4]. Similarly, in assessing cannabis extract effects on NK cells, LDH release provided evidence of dose-dependent cytotoxicity that was confirmed by flow cytometry analysis of apoptosis markers [3].

Data Normalization

When comparing across experiments, normalize percent cytotoxicity values to the positive control (100% lysis) and negative control (0% cytotoxicity). For time-course experiments, express results as area under the curve or as the concentration required to achieve 50% cytotoxicity (IC50).

Troubleshooting

Limitations

Specificity and Mechanism

The LDH assay measures membrane integrity but does not distinguish between different cell death mechanisms. Both necrosis and late-stage apoptosis result in LDH release, while early apoptosis may not be detected. For mechanistic studies, combine LDH assay with apoptosis-specific assays such as caspase-3/7 activity measurement or annexin V staining [1][3].

Sensitivity to Cell Density

The assay's dynamic range depends on cell number. At very low cell densities, the signal may be insufficient for reliable quantification. At very high densities, spontaneous release may increase due to nutrient depletion or contact inhibition. Optimize cell density for each cell type and experimental condition.

Interference from Test Compounds

Many compounds can interfere with the LDH detection reaction. Reducing agents (e.g., dithiothreitol, β-mercaptoethanol) can directly reduce the tetrazolium salt, producing false-positive signals. Metal ions, particularly copper and iron, can inhibit diaphorase activity. Always include compound-only controls and perform interference checks.

Time Dependence

LDH is a stable enzyme, but its activity can decrease over time in culture supernatants, particularly at 37°C. Collect supernatants promptly after treatment and process immediately, or store at 4°C for up to 24 hours. For longer storage, freeze at -20°C or -80°C, but avoid repeated freeze-thaw cycles.

Not Suitable for All Sample Types

The LDH assay is optimized for cell culture supernatants. It is not directly applicable to tissue homogenates, blood samples, or other complex biological fluids without extensive validation and sample preparation.

Documentation and Reporting

Essential Documentation

• Cell line information: Source, passage number, authentication status, mycoplasma testing results
• Culture conditions: Medium composition, serum concentration, antibiotic use, incubation parameters
• Seeding density: Cells per well, plate format, attachment time
• Treatment details: Compound concentrations, vehicle, treatment duration, number of replicates
• Assay conditions: Kit manufacturer and catalog number, reagent volumes, incubation time and temperature, detection wavelength
• Raw data: Absorbance or fluorescence values for all wells, including controls
• Calculations: Background-subtracted values, percent cytotoxicity, statistical analysis method
• Quality control metrics: Spontaneous release percentage, coefficient of variation for replicates, positive control performance

Reporting Standards

Follow the MIAME (Minimum Information About a Microarray Experiment) or similar guidelines for cell-based assays. Report the number of independent experiments (biological replicates) and technical replicates. Include error bars representing standard deviation or standard error of the mean. Specify the statistical test used and the significance threshold.

Biosafety Considerations

The LDH assay as described here is a BSL-1 procedure when using non-pathogenic, established cell lines (e.g., SH-SY5Y, HeLa, fibroblasts) that are free from adventitious agents. Follow standard BSL-1 practices as outlined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition [6]:

• Perform all work in a Class II biological safety cabinet when handling live cells
• Decontaminate all liquid waste with appropriate disinfectant (e.g., 10% bleach) before disposal
• Use personal protective equipment: lab coat, gloves, and eye protection
• Label all plates and tubes clearly with cell line, date, and hazard information
• Maintain a clean work surface and decontaminate after each use
• Follow institutional biosafety committee guidelines for cell culture work

For work with recombinant or synthetic nucleic acids, consult the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7]. If using cell lines that may contain latent viruses or other infectious agents, consult your institutional biosafety officer for appropriate containment level.

Frequently Asked Questions

Q1: Can I use the LDH assay with suspension cells? Yes, the LDH assay works well with suspension cells. The key modification is that you must centrifuge the cell suspension (250–300 × g for 5 minutes) to pellet the cells before collecting the supernatant for LDH measurement. Include a centrifugation step in your protocol to ensure that intact cells are removed from the supernatant. The spontaneous release control should be handled identically to the treatment groups.

Q2: How do I choose between colorimetric and fluorometric LDH detection? Colorimetric detection is suitable for most applications and is more economical, requiring only a standard absorbance microplate reader. Fluorometric detection offers 10–100 times greater sensitivity, making it preferable for low-cell-density experiments, when minimal cytotoxicity is expected, or when working with precious samples. However, fluorometric assays are more susceptible to interference from fluorescent compounds and require a fluorescence-capable plate reader.

Q3: Why is my spontaneous LDH release consistently high? High spontaneous release (>15% of maximum) indicates that your cells are stressed or damaged before treatment. Common causes include: overconfluence at the time of treatment, rough handling during medium changes (e.g., pipetting directly onto the cell monolayer), prolonged time between medium change and supernatant collection, or poor culture conditions (e.g., incorrect pH, temperature fluctuations, mycoplasma contamination). Reduce seeding density, handle plates gently, and verify culture conditions. Test for mycoplasma contamination if the problem persists.

Q4: Can I reuse the same plate for LDH assay and another endpoint? It is not recommended to use the same plate for LDH assay and other endpoints because the LDH detection reagent contains components that may interfere with other assays. Additionally, the lysis step for maximum release control will kill cells in those wells. If you need multiple endpoints from the same experiment, seed replicate plates and process each plate for a different assay. Alternatively, collect supernatant for LDH assay and then use the remaining cells for a different assay (e.g., MTT), but validate that the LDH detection reagent does not interfere with the second assay.

References and Further Reading

1. Investigation of the Effects of Saffron on Neuroprotection and Circadian Rhythm in an In Vitro Parkinson's Model - Study using LDH assay alongside MTT to assess neuroprotection in SH-SY5Y cells
2. Evaluation of Post-Processing Time's Influence on Biocompatibility of 3D-Printed Denture Base Resins - Application of LDH assay for biocompatibility testing of dental materials
3. Mitochondrial dysfunction and autophagy activation underlie NK cell impairment induced by Cannabis - LDH assay used to assess cytotoxicity in immune cells
4. Antitumoral efficacy of silver nanoparticles reduced with β-D-glucose on a canine transmissible venereal tumor cell line - Cytotoxicity assessment using complementary viability assays
5. In vitro tolerability of soluble silicic acid and tetraethyl orthosilicate in ocular epithelial cells - Comparison of LDH release with metabolic activity assays for nanomaterial safety evaluation
6. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition - Authoritative biosafety guidelines for laboratory work
7. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules - Regulatory framework for recombinant nucleic acid research
8. NCBI Bookshelf: Molecular Biology and Laboratory Methods - Comprehensive collection of biomedical methods references

Related Articles

• Colony Formation Assay Protocol: Measuring Cell Reproductive Viability
• MTS Assay Protocol: Cell Proliferation and Viability Measurement
• Transwell Migration Assay Protocol: Measuring Cell Migration and Invasion
• Cytotoxicity Assay: Overview of LDH, MTT, and ATP-Based Methods
• Kinase Activity Assay: Methods for Measuring Protein Kinase Activity
• Enzyme Activity Assay: Principles and Protocol for Measuring Catalytic Activity